ID
41468
Description
Study ID: 105043/013 Clinical Study ID: 105043/013 Study Title: An Open-Label Study of Argatroban Injection to Evaluate the Safety and Effectiveness in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin (Protocol SKF105043/013) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00039858 - See https://clinicaltrials.gov/ct2/show/NCT00039858 Sponsor: GlaxoSmithKline Collaborators: Encysive Pharmaceuticals Phase: Phase 4 Study Recruitment Status: Completed Generic Name: Argatroban Trade Name: N/A Study Indication: Thrombosis This Study evaluates the safety and the efficacy of i.v. Argatroban treatment in paediatric patients which require anticoagulants but aren't suitable for Heparin treatment. The study consists of screening visit (pre-treatment examination), treatment period of maximum 14 days after reaching therapeutical dose, post-treatment visit (once the treatment is stopped or after 14 days) and a follow-up visit which follows 30 days (+/- 14 days) after clinical resolution of underlying condition or after the end of the 14-day study period. Treatment can be continued after the 14-day study period if needed but such treatment isn't part of this Study. The Surgery / Invasive Procedure Information Form has to be filled in whenever the patient undergoes surgery or other invasive procedure during the study period.
Link
https://clinicaltrials.gov/ct2/show/NCT00039858
Keywords
Versions (1)
- 10/20/20 10/20/20 -
Copyright Holder
GlaxoSmithKline
Uploaded on
October 20, 2020
DOI
To request one please log in.
License
Creative Commons BY-NC 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Safety and Efficacy of Argatroban in Pediatric Patients, NCT00039858
Surgery / Invasive Procedure Information
- StudyEvent: ODM
Description
Did the patient undergo surgery or other invasive procedure during the study period?
Alias
- UMLS CUI-1
- C0543467
- UMLS CUI-2
- C4048276
- UMLS CUI-3
- C0347984
- UMLS CUI-4
- C0008976
Description
Surgery / Invasive Procedure Information
Alias
- UMLS CUI-1
- C0543467
- UMLS CUI-2
- C4048276
Description
Type of surgery/procedure
Data type
text
Alias
- UMLS CUI [1,1]
- C0543467
- UMLS CUI [1,2]
- C0455713
- UMLS CUI [2,1]
- C4048276
- UMLS CUI [2,2]
- C0455713
Description
(dd-mmm-yyyy)
Data type
date
Alias
- UMLS CUI [1,1]
- C0543467
- UMLS CUI [1,2]
- C0011008
- UMLS CUI [2,1]
- C4048276
- UMLS CUI [2,2]
- C0011008
Description
(0000-2359)
Data type
time
Alias
- UMLS CUI [1,1]
- C0543467
- UMLS CUI [1,2]
- C0040223
- UMLS CUI [2,1]
- C4048276
- UMLS CUI [2,2]
- C0040223
Description
Indication of surgery/invasive procedure
Data type
text
Alias
- UMLS CUI [1,1]
- C3146298
- UMLS CUI [1,2]
- C0543467
- UMLS CUI [2,1]
- C3146298
- UMLS CUI [2,2]
- C4048276
Similar models
Surgery / Invasive Procedure Information
- StudyEvent: ODM
C0019994 (UMLS CUI [1,2])
C2348184 (UMLS CUI [1,2])
C4048276 (UMLS CUI-2)
C0347984 (UMLS CUI-3)
C0008976 (UMLS CUI-4)
C0347984 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C4048276 (UMLS CUI [2,1])
C0347984 (UMLS CUI [2,2])
C0008976 (UMLS CUI [2,3])
C4048276 (UMLS CUI-2)
C0455713 (UMLS CUI [1,2])
C4048276 (UMLS CUI [2,1])
C0455713 (UMLS CUI [2,2])
C0011008 (UMLS CUI [1,2])
C4048276 (UMLS CUI [2,1])
C0011008 (UMLS CUI [2,2])
C0040223 (UMLS CUI [1,2])
C4048276 (UMLS CUI [2,1])
C0040223 (UMLS CUI [2,2])
C0543467 (UMLS CUI [1,2])
C3146298 (UMLS CUI [2,1])
C4048276 (UMLS CUI [2,2])